Khalid Muhammad

4.2k total citations · 2 hit papers
76 papers, 2.1k citations indexed

About

Khalid Muhammad is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Khalid Muhammad has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 25 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Khalid Muhammad's work include T-cell and B-cell Immunology (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Signaling Pathways in Disease (9 papers). Khalid Muhammad is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Signaling Pathways in Disease (9 papers). Khalid Muhammad collaborates with scholars based in United Arab Emirates, Pakistan and Germany. Khalid Muhammad's co-authors include Yasir Waheed, Shiza Malik, Edgar Serfling, Andreas Kerstan, Matthias Goebeler, Petra Roll, Thomas Dörner, ‏Helal F. Hetta, Hans‐Peter Tony and Hermann Einsele and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Khalid Muhammad

73 papers receiving 2.0k citations

Hit Papers

Nanotechnology: A Revolution in Modern Industry 2023 2026 2024 2025 2023 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nanotechnology: A Revolution in Modern Industry
    2023 499 citations Shiza Malik, Khalid Muhammad et al. Molecules profile →
  2. Emerging Applications of Nanotechnology in Healthcare and Medicine
    2023 223 citations Shiza Malik, Khalid Muhammad et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Muhammad United Arab Emirates 21 540 493 366 267 191 76 2.1k
А. В. Караулов Russia 27 556 1.0× 453 0.9× 554 1.5× 461 1.7× 251 1.3× 223 3.0k
Tak‐Wah Wong Taiwan 22 293 0.5× 328 0.7× 129 0.4× 425 1.6× 401 2.1× 68 2.0k
Lijian Jin Hong Kong 27 165 0.3× 419 0.8× 538 1.5× 264 1.0× 99 0.5× 94 3.2k
Carolina Constantin Romania 34 593 1.1× 979 2.0× 289 0.8× 365 1.4× 374 2.0× 136 3.5k
Sang Wook Son South Korea 29 332 0.6× 728 1.5× 526 1.4× 517 1.9× 779 4.1× 147 2.6k
George Han United States 21 274 0.5× 552 1.1× 215 0.6× 471 1.8× 491 2.6× 84 3.4k
Mi Jin Park South Korea 27 470 0.9× 864 1.8× 164 0.4× 223 0.8× 58 0.3× 147 3.0k
Hsien‐Yi Chiu Taiwan 30 927 1.7× 260 0.5× 123 0.3× 235 0.9× 718 3.8× 106 2.3k
Li‐Chen Chen Taiwan 27 449 0.8× 462 0.9× 76 0.2× 216 0.8× 107 0.6× 130 2.4k

Countries citing papers authored by Khalid Muhammad

Since Specialization
Citations

This map shows the geographic impact of Khalid Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Muhammad more than expected).

Fields of papers citing papers by Khalid Muhammad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Muhammad. The network helps show where Khalid Muhammad may publish in the future.

Co-authorship network of co-authors of Khalid Muhammad

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Muhammad. A scholar is included among the top collaborators of Khalid Muhammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Muhammad. Khalid Muhammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muhammad, Khalid, et al.. (2025). Delving Into Nanoparticle Systems for Enhanced Drug Delivery Technologies. AAPS PharmSciTech. 26(3). 74–74. 4 indexed citations
2.
Khan, Mir Azam, Bincy Baby, Priti Mudgil, et al.. (2025). Functional profiling of synthetic camel milk-derived peptides with implication in glucose transport and diabetes. PLoS ONE. 20(3). e0320812–e0320812. 2 indexed citations
3.
Klein-Heßling, Stefan, et al.. (2024). NFATc1 Fosters Allergic Contact Dermatitis Responses by Enhancing the Induction of IL-17–Producing CD8 Cells. Journal of Investigative Dermatology. 145(8). 1995–2006.e5. 5 indexed citations
4.
Murti, Krisna, Vanessa Wild, Khalid Muhammad, et al.. (2023). Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells. Frontiers in Oncology. 13. 1205788–1205788. 1 indexed citations
5.
Malik, Shiza, Khalid Muhammad, & Yasir Waheed. (2023). Nanotechnology: A Revolution in Modern Industry. Molecules. 28(2). 661–661. 499 indexed citations breakdown →
6.
Malik, Shiza, et al.. (2023). Respiratory Syncytial Virus Infection: Treatments and Clinical Management. Vaccines. 11(2). 491–491. 8 indexed citations
7.
Semlali, Abdelhabib, et al.. (2023). Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence. Antioxidants. 12(6). 1159–1159. 43 indexed citations
8.
Alneyadi, Aysha, Khalid Muhammad, Ali H. Eid, et al.. (2023). The SARS-CoV-2 Spike Protein Activates the Epidermal Growth Factor Receptor-Mediated Signaling. Vaccines. 11(4). 768–768. 14 indexed citations
9.
Khan, Mir Azam, Mohammad Azam Ansari, Shahab Uddin, et al.. (2022). Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective. Life. 12(7). 990–990. 6 indexed citations
10.
Muhammad, Khalid, Mohammed Akli Ayoub, & Rabah Iratni. (2021). Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?. Current Pharmaceutical Design. 27(18). 2141–2150. 10 indexed citations
11.
Ayoub, Mohammed Akli, et al.. (2021). Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis. Cells. 10(6). 1392–1392. 59 indexed citations
12.
Mahmood, Zafar, ‏Helal F. Hetta, Nayla Munawar, et al.. (2020). Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies. Vaccines. 8(3). 443–443. 14 indexed citations
13.
Ellah, Noura H. Abd, et al.. (2020). Nanomedicine as A Promising Approach For Diagnosis, Treatment and Prophylaxis Against COVID-19. Nanomedicine. 15(21). 2085–2102. 60 indexed citations
14.
Muhammad, Khalid, et al.. (2016). Isolation and molecular characterization of Pasteurella multocida from commercial layer flocks suffering from respiratory syndromes.. The Journal of Animal and Plant Sciences. 26(1). 304–308. 2 indexed citations
15.
Klein-Heßling, Stefan, Ronald Rudolf, Khalid Muhammad, et al.. (2016). A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development. Nature Communications. 7(1). 11841–11841. 17 indexed citations
16.
Anjum, Aftab Ahmad, et al.. (2014). Studies on the antibiotic sensitivity pattern of isolates of P. multocida from buffaloes.. The Journal of Animal and Plant Sciences. 24(5). 1565–1568. 1 indexed citations
17.
Muhammad, Khalid, et al.. (2013). OPTIMIZATION OF PHYSICO-CHEMICAL FACTORS AUGMENTING IN VITRO BIOMASS PRODUCTION OF PASTEURELLA MULTOCIDA. The Journal of Animal and Plant Sciences. 23(4). 1085–1088. 3 indexed citations
18.
Muhammad, Khalid, et al.. (2013). Antimicrobial activity of mentofin and its effect on antibody response of broilers to Newcastle Disease virus vaccine.. The Journal of Animal and Plant Sciences. 23(4). 1008–1011. 11 indexed citations
19.
Roll, Petra, Khalid Muhammad, Stefan Kleinert, et al.. (2011). In vivo effects of the anti–interleukin‐6 receptor inhibitor tocilizumab on the B cell compartment. Arthritis & Rheumatism. 63(5). 1255–1264. 78 indexed citations
20.
Das, Panchanan, et al.. (1998). STANDARDIZATION OF INDIRECT HAEMAGGLUriON TEST FOR MONITORING PASTEURELLA MULTOCIDA ANTIBODIES. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by А. В. Караулов Breakdown of academic impact, for papers by Tak‐Wah Wong Breakdown of academic impact, for papers by Lijian Jin Breakdown of academic impact, for papers by Carolina Constantin Breakdown of academic impact, for papers by Sang Wook Son Breakdown of academic impact, for papers by George Han Breakdown of academic impact, for papers by Mi Jin Park Breakdown of academic impact, for papers by Hsien‐Yi Chiu Breakdown of academic impact, for papers by Li‐Chen Chen
Rankless by CCL
2026